Bipartisan congressional lawmakers are seeking input from experts about how to best set up a regulatory framework for the therapeutic use of psychedelics such as psilocybin and MDMA. Reps. Jack Bergman (R-MI) and Lous Correa (D-CA), founders of the Congressional Psychedelics Advancing Therapies (PATH) Caucus, released a request for information from the public last month. … Continue reading Congressional Caucus Seeks Input On Psychedelic Therapy To Inform Development Of Regulated Access Model